• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Cytotoxic and DNA-inhibitory effects of iron chelators on human leukaemic cell lines.

作者信息

Kontoghiorghes G J, Piga A, Hoffbrand A V

出版信息

Hematol Oncol. 1986 Jul-Sep;4(3):195-204. doi: 10.1002/hon.2900040303.

DOI:10.1002/hon.2900040303
PMID:3095210
Abstract

Cytotoxic and DNA synthesis inhibitory effects of several iron chelators with different physicochemical properties have been tested in four myeloid leukaemic cell lines (U937, K562, ML2 and HL60). The small lipophilic chelators 8-hydroxyquinoline, tropolone and omadine at 2 X 10(-5) M, caused substantial inhibition of labelled leucine and thymidine uptake into cells and also cell death following 4-h incubation. These effects were approximately 10-fold increased when the drugs were pre-incubated with equimolar amounts of iron. Iron alone and hydrophilic chelators e.g. desferrioxamine had insignificant cytotoxic and DNA synthesis inhibitory effects under the same conditions.

摘要

相似文献

1
Cytotoxic and DNA-inhibitory effects of iron chelators on human leukaemic cell lines.
Hematol Oncol. 1986 Jul-Sep;4(3):195-204. doi: 10.1002/hon.2900040303.
2
Cytotoxic effects of the lipophilic iron chelator omadine.亲脂性铁螯合剂奥马汀的细胞毒性作用。
FEBS Lett. 1986 Aug 18;204(2):208-12. doi: 10.1016/0014-5793(86)80813-4.
3
Variation in iron accumulation, transferrin membrane binding and DNA synthesis in the K-562 and U-937 cell lines induced by chelators and their iron complexes.
Eur J Haematol. 1987 Oct;39(4):318-25. doi: 10.1111/j.1600-0609.1987.tb00776.x.
4
New 8-hydroxyquinoline and catecholate iron chelators: influence of their partition coefficient on their biological activity.新型8-羟基喹啉和儿茶酚铁螯合剂:其分配系数对生物活性的影响。
Biochem Pharmacol. 2001 Nov 15;62(10):1355-62. doi: 10.1016/s0006-2952(01)00779-1.
5
Interaction of gallium nitrate with fludarabine and iron chelators: effects on the proliferation of human leukemic HL60 cells.硝酸镓与氟达拉滨及铁螯合剂的相互作用:对人白血病HL60细胞增殖的影响。
Cancer Res. 1990 Oct 15;50(20):6466-70.
6
Iron mobilization, cytoprotection, and inhibition of cell proliferation in normal and transformed rat hepatocyte cultures by the hydroxypyridinone CP411, compared to CP20: a biological and physicochemical study.与CP20相比,羟基吡啶酮CP411在正常和转化大鼠肝细胞培养物中的铁动员、细胞保护及细胞增殖抑制作用:一项生物学和物理化学研究
Biochem Pharmacol. 2004 Apr 15;67(8):1479-87. doi: 10.1016/j.bcp.2003.12.019.
7
Exogenous intracellular, but not extracellular, iron augments myocardial reperfusion injury.
Am J Physiol. 1994 Feb;266(2 Pt 2):H384-92. doi: 10.1152/ajpheart.1994.266.2.H384.
8
Iron at the cell surface controls DNA synthesis in CCl 39 cells.细胞表面的铁控制CCl 39细胞中的DNA合成。
Biochem Biophys Res Commun. 1994 Aug 30;203(1):16-21. doi: 10.1006/bbrc.1994.2142.
9
Effect of orally active hydroxypyridinone iron chelators on human lymphocyte function.口服活性羟基吡啶酮铁螯合剂对人淋巴细胞功能的影响。
Br J Haematol. 1992 Sep;82(1):13-9. doi: 10.1111/j.1365-2141.1992.tb04587.x.
10
Examination of the antiproliferative activity of iron chelators: multiple cellular targets and the different mechanism of action of triapine compared with desferrioxamine and the potent pyridoxal isonicotinoyl hydrazone analogue 311.铁螯合剂抗增殖活性的研究:与去铁胺及强效吡啶醛异烟酰腙类似物311相比,曲安西龙的多个细胞靶点及不同作用机制
Clin Cancer Res. 2003 Jan;9(1):402-14.

引用本文的文献

1
Increased Free Radical Generation during the Interaction of a Quinone-Quinoline Chelator with Metal Ions and the Enhancing Effect of Light.醌-喹啉螯合剂与金属离子相互作用过程中自由基生成增加及光的增强作用
Pharmaceuticals (Basel). 2023 Aug 8;16(8):1116. doi: 10.3390/ph16081116.
2
Metal Complexes of Omadine (-Hydroxypyridine-2-thione): Differences of Antioxidant and Pro-Oxidant Behavior in Light and Dark Conditions with Possible Toxicity Implications.奥马汀(-羟基吡啶-2-硫酮)金属配合物:在光照和黑暗条件下抗氧化和促氧化行为的差异及其可能的毒性意义。
Molecules. 2023 May 20;28(10):4210. doi: 10.3390/molecules28104210.
3
Deferiprone and Iron-Maltol: Forty Years since Their Discovery and Insights into Their Drug Design, Development, Clinical Use and Future Prospects.
地拉罗司和铁-麦芽酚:从发现到药物设计、研发、临床应用及未来前景的四十年。
Int J Mol Sci. 2023 Mar 4;24(5):4970. doi: 10.3390/ijms24054970.
4
New Iron Metabolic Pathways and Chelation Targeting Strategies Affecting the Treatment of All Types and Stages of Cancer.新型铁代谢途径和螯合靶向策略影响各种类型和阶段癌症的治疗。
Int J Mol Sci. 2022 Nov 13;23(22):13990. doi: 10.3390/ijms232213990.
5
Questioning Established Theories and Treatment Methods Related to Iron and Other Metal Metabolic Changes, Affecting All Major Diseases and Billions of Patients.质疑与铁及其他金属代谢变化相关的既定理论和治疗方法,影响所有主要疾病和数十亿患者。
Int J Mol Sci. 2022 Jan 25;23(3):1364. doi: 10.3390/ijms23031364.
6
Mechanistic Insights of Chelator Complexes with Essential Transition Metals: Antioxidant/Pro-Oxidant Activity and Applications in Medicine.具有必需过渡金属的螯合物配合物的作用机制研究:抗氧化/促氧化活性及其在医学中的应用。
Int J Mol Sci. 2022 Jan 23;23(3):1247. doi: 10.3390/ijms23031247.
7
New Era in the Treatment of Iron Deficiency Anaemia Using Trimaltol Iron and Other Lipophilic Iron Chelator Complexes: Historical Perspectives of Discovery and Future Applications.使用三价麦芽酚铁和其他亲脂性铁螯合剂复合物治疗缺铁性贫血的新时代:发现的历史视角和未来应用。
Int J Mol Sci. 2021 May 24;22(11):5546. doi: 10.3390/ijms22115546.
8
Trying to Solve the Puzzle of the Interaction of Ascorbic Acid and Iron: Redox, Chelation and Therapeutic Implications.试图解开抗坏血酸与铁相互作用之谜:氧化还原、螯合作用及治疗意义
Medicines (Basel). 2020 Jul 30;7(8):45. doi: 10.3390/medicines7080045.
9
Invasion inhibition in pancreatic cancer using the oral iron chelating agent deferasirox.使用口服铁螯合剂地拉罗司抑制胰腺癌侵袭。
BMC Cancer. 2020 Jul 22;20(1):681. doi: 10.1186/s12885-020-07167-8.
10
Iron and Chelation in Biochemistry and Medicine: New Approaches to Controlling Iron Metabolism and Treating Related Diseases.铁与螯合作用在生物化学和医学中的应用:控制铁代谢和治疗相关疾病的新方法。
Cells. 2020 Jun 12;9(6):1456. doi: 10.3390/cells9061456.